Mexidol is a preparation with polycomponent range of pharmacological effects and multifactor mechanism of action. Its antioxidative, membrane-acting effects, ability to modulate the functioning of receptors and membrane-bound enzymes, to restore neurotransmitter balance are the key elements of Mexidol's mechanism of action. Mexidol's uppermost action is aimed at the processes of radical oxidation. On the one hand, the drug inhibits the processes of lipid peroxidation, and on the other hand, it improves the potency of antioxidant enzymes. In addition, it holds a hypolipidemic action.
Pharmasoft opened a representative office in the Republic of Kazakhstan
Pharmasoft now has officially registered a representative office in the Republic of Kazakhstan at: Karaganda, bul. Mira, 15, office # 206. The Chief of the representative office in the Republic of Kazakhstan is Mr. Greidin Dmitry Gennadievich.
Attention! New indications introduced to the instruction
Federal Service for Surveillance in Healthcare and Social Development (Roszdravnadzor) approved introduction of indications to the directions for use of the following Mexidol dosage form: Solution for intravenous and intramuscular injection, 50 mg/ml, for craniocerebral injury and its consequences.
New dosage form “For in-patient hospital departments”
In order to make the efficient and safe preparation of Mexidol ® more accessible to the patients, as well as to ensure better medications supply to the hospitals of Russian healthcare system, the management of Pharmasoft decided to initiate production of Mexidol ® in packages of 50 ampoules (2 ml.), and in packages of 20 ampoules (5 ml.) with marking "For in-patient hospital departments"